Financial reports
ARS
2024 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-K/A
2022 FY
Annual report (amended)
30 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Current reports
8-K
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
21 Mar 24
8-K
Absci Announces Proposed Public Offering of Common Stock
28 Feb 24
8-K
Results of Operations and Financial Condition
27 Feb 24
8-K
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
8 Jan 24
8-K
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
20 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
4 Dec 23
8-K
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
14 Nov 23
8-K
Other Events
5 Sep 23
8-K
Departure of Directors or Certain Officers
17 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
21 Mar 24
424B5
Prospectus supplement for primary offering
28 Feb 24
424B5
Prospectus supplement for primary offering
27 Feb 24
424B5
Prospectus supplement for primary offering
16 Jun 23
S-8
Registration of securities for employees
30 Mar 23
S-3
Shelf registration
24 Aug 22
S-8
Registration of securities for employees
22 Mar 22
S-8
Registration of securities for employees
27 Jul 21
424B4
Prospectus supplement with pricing info
23 Jul 21
8-A12B
Registration of securities on exchange
21 Jul 21
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
11 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
Other
UPLOAD
Letter from SEC
1 Jun 23
CORRESP
Correspondence with SEC
24 May 23
UPLOAD
Letter from SEC
15 May 23
EFFECT
Notice of effectiveness
6 Sep 22
CORRESP
Correspondence with SEC
31 Aug 22
UPLOAD
Letter from SEC
26 Aug 22
EFFECT
Notice of effectiveness
22 Jul 21
CERT
Certification of approval for exchange listing
21 Jul 21
CORRESP
Correspondence with SEC
20 Jul 21
SEC STAFF
SEC staff action: Order
20 Jul 21
Ownership
4
Sean McClain
21 Mar 24
4
Jeremy Green
5 Mar 24
SC 13D/A
Redmile Group, LLC
5 Mar 24
SC 13G/A
Phoenix Venture Partners II LP
14 Feb 24
5
Annual statement of changes in insider ownership
14 Feb 24
SC 13G
McClain Sean
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Todd Bedrick
5 Feb 24
4
Andreas Busch
5 Feb 24
4
Zachariah Jonasson
5 Feb 24